We report a molecular nanoassembly able to supply simultaneously, in the same region of space and under the exclusive control of visible light, nitric oxide and singlet oxygen, two species playing a key role in the therapy of cancer; the considerable fluorescence of this nanoaggregate and its reduced size (ca. 40 nm) represent additional advantages that make this photoactive vehicle an appealing candidate to be tested in biological systems.
No takes yet. Share an insight, caveat, or question.
Caruso et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: